Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs. Xap Therapeutics wasestablished in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.

Health Diagnostics

Health Care

Biotechnology

Xap Therapeutics

Katie Hall, PhD

James Patterson

Laurent Jespers

Josie Stevens

Shaun Foy

Research and Development

Leadership Team

Teams at Xap Therapeutics

Research and Development

Leadership Team